Sourcing Blarcamesine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Sourcing Blarcamesine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Blarcamesine is an experimental drug candidate investigated for Alzheimer's disease and other conditions. It is supplied as a pharmaceutical raw material for research and development purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
The international HS code for Blarcamesine (CAS 195615-83-9) is 2932.19.
2932.19
2932 19 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-(2,2-diphenyloxolan-3-yl)-N,N-dimethylmethanamine
BOTHKNZTGGXFEQ-UHFFFAOYSA-N
CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3